Demonstrates enhanced analyte detection in crude samples using a cloud-based app, suggesting improved POCT reliability.
Point-of-care testing (POCT) faces challenges in robustly detecting trace analytes because of its limited ability to distinguish weak target signals from background noise, resulting in a risk of false-negative results. We present a deep learning (DL)-driven POCT assay based on commercial strips that allows for the robust detection of crudely extracted samples, and thus more reliable and quantitative detection compared with conventional intensity-based analysis. The assay leverages a target-responsive DNA hydrogel functionalized with recognition molecules and offers a general principle for the detection of diverse analytes. Rather than conventional intensity-based image analysis, the assay employs a DL tool as the signal readout to mitigate test variability and enhance subtle signals. Furthermore, a cloud-based smartphone application streamlines the user experience to provide intuitive and reliable detection results within seconds. We show that the DL-powered approach effectively distinguishes low-concentration positive signals and background, achieving over 90.0% accuracy, and demonstrating improved performance compared with traditional grayscale analysis. It significantly enhances sensitivity by 2- to 5-fold and expands the detection range by an order of magnitude for small-molecule mycotoxins. The platform enables the rapid and accurate quantification of mycotoxin in diverse contaminated food samples, with an average accuracy of 92.4%. This approach demonstrates strong agreement with standard laboratory methods in complex sample analysis and an improvement in POCT applicability compared with conventional readout methods.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: